MedTrace Logo

IL-38 Evaluation as a Biomarker in Pediatric Asthma

NCT05366491 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2022-05-12

No results posted yet for this study

Summary

The aim of this study is to investigate the associations between serum IL-38 levels and different variables of asthma in children such as laboratory variables, pulmonary function test results, the diagnosis of asthma, and in correlation with disease severity.

Conditions

  • Bronchial Asthma

Interventions

DIAGNOSTIC_TEST

Il-38 serum level

measurement of serum levels of IL-38

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Asmaa Kamal, Ass prof · Assistant professor

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2021-01-12
Completion
2021-04-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05366491 on ClinicalTrials.gov